Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN)

13.83 -0.17 (1.21%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26 *Est.)

Latest Headlines

Amarin presents new REDUCE-IT data at ESC Congress 2026 August 31, 2026 8:15 AM - StreetInsider Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026 August 31, 2026 8:15 AM - StreetInsider Amarin presents REDUCE-IT legacy analysis at ESC Congress 2026 August 28, 2026 8:16 AM - StreetInsider New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Pat August 28, 2026 8:15 AM - StreetInsider Amarin to present REDUCE-IT analyses at ESC Congress 2026 August 24, 2026 8:17 AM - StreetInsider New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026 August 24, 2026 8:15 AM - StreetInsider JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight August 21, 2026 3:28 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Aug 01 Filed by: Fishman Peter L. August 3, 2026 4:31 PM - SEC Filing Amarin Corp. (AMRN) Reports In-Line Q2 EPS July 29, 2026 7:26 AM - StreetInsider Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence July 29, 2026 7:00 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Keenan David Paul July 15, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Ketchum Steven B July 15, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Fishman Peter L. July 15, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Provoost Jonathan July 15, 2026 5:00 PM - SEC Filing Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026 July 15, 2026 8:00 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Jun 26 Filed by: Berg Aaron June 30, 2026 5:20 PM - SEC Filing Amarin highlights Vascepa cost advantage over new injectable rivals June 30, 2026 4:16 PM - StreetInsider Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape  June 30, 2026 4:15 PM - StreetInsider Full Article List